Related Experiment Video
Updated: Aug 6, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Monoclonal Antibodies for COVID-19 in Children: Case Series Should be Just the Start
Zheyi Teoh1, Zachary I Willis2
1Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Insights
Two new studies guide pediatric COVID-19 treatment using monoclonal antibodies. Further research is essential for monoclonal antibodies and other therapies in children.
Area of Science:
- Pediatric infectious diseases
- Immunology
- Pharmacology
Background:
- COVID-19 presents unique challenges in pediatric populations.
- Monoclonal antibodies have emerged as a potential therapeutic option.
- Guidance for pediatric use of these therapies is developing.
Abstract:
Two new articles describe the use and implementation of monoclonal antibodies to treat COVID-19 in children. While these studies provide valuable guidance for pediatric clinicians, more studies of monoclonal antibodies and other COVID-19 therapies in children are needed.

